双介入治疗糖尿病足的临床研究  

Study on Double Interventional Treatment for Diabetic Foot

作　　者：王东盛[1] 王成纲[1] 陆英[1] 刘明[1] 刘海洋[1] 

机构地区：[1]北京煤炭总医院介入科,北京100028

出　　处：《中国医药导刊》2011年第5期771-773,共3页Chinese Journal of Medicinal Guide

摘　　要：目的:探讨经皮腔内成形术(PTA)联合经皮动脉穿刺导管药盒系统(PCS)治疗糖尿病足的临床疗效。方法:60例糖尿病足患者,行PTA术治疗后,再于皮下植入动脉药盒系统,并经动脉连接导管系统行前列地尔注射液、丹参注射液灌注治疗。14天为1疗程,共治疗2个疗程。治疗前后测定踝臂指数(ABI)。结果:全部糖尿病足患者,治愈38例,有效20例,无效2例,总有效率96.7%。治疗前ABI为0.32±0.11,治疗后ABI为0.76±0.14,(治疗前后比较P=0.000)。结论:PTA联合PCS灌注药物对糖尿病足有明显治疗作用,疗效满意,能有效改善下肢血液循环。Objective：To investigate the clinical efficacy of percutaneous transluminal angioplasty（PTA）and percutaneous intra-arterial femoral port-catheter system（PCS） for treatment for diabetic foot.Methods：60 patients with diabetic foot were treated by PTA and using alprostadil injection and salvia miltiorrhiza injection via PCS.The patients were treated in 4 weeks. Ankle brachial indexs（ABI） were examined before and after treaments.Results：The effective percentage of treatment were 96.7%.There were significant difference of the AB1 between before and after treaments.Conclusion：The technique of PTA and PCS implatation for interventional treatment for diabetic foot is available.

关 键 词：糖尿病足 经皮腔内成形术 导管药盒系统 踝臂指数 双介入 

分 类 号：R587.2[医药卫生—内分泌]